StockData
Damora Therapeutics, Inc. logo

Damora Therapeutics, Inc. (DMRA) stock

DMRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$22.98+0.42 (+1.86%)

Close on Nov 18, 2026Market cap $1.42BP/E 5.8Yield 0.00%

Damora Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Damora Therapeutics's market cap was $1.44B on Nov 11, 2026, against $23.60M a year earlier. Over the last 5 years it ranged from $3.69M to $1.75B, with a median of $33.09M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.44B+4600.0%
2025Dec 31, 2025$30.54M+423.8%
2024Dec 31, 2024$5.83M-70.1%
2023Dec 29, 2023$19.52M-33.6%
2022Dec 30, 2022$29.42M-61.6%
2021Dec 31, 2021$76.54M+2253.5%
2020Dec 31, 2020$3.25M–

More Damora Therapeutics figures

See a number that looks wrong?